Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up Women only

Using Epsom salt compresses to relieve postpartum perineal pain

Official title: If the Use of Epsom Salt (magnesium Sulfate) Compresses 25% Effective in Relieving Perineal Pain in Immediate Postpartum Patients?

Run by Université de Sherbrooke · NCT06393608 · Data updated 2026-11-12

This study is testing if Epsom salt compresses can help women feel less pain in their perineal area after giving birth.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment90 (estimated)
SponsorUniversité de Sherbrooke
Academic / other
Locations4 sites (Chicoutimi, Quebec and 3 other locations)
StatusRecruiting
StartedJune 15, 2024
Main results expectedDecember 15, 2025
Study endsJune 30, 2026
Registry record updatedDecember 19, 2024
Trial IDNCT06393608 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women who have just given birth vaginally and report perineal or vulvar pain of 3/10 or more.

Probably not a fit

Patients who have undergone a cesarean section or have hemodynamic instability will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of compresses soaked in 25% magnesium sulfate for alleviating perineal pain in women after vaginal childbirth. Participants will be randomly assigned to receive either the magnesium sulfate treatment or a placebo (water-soaked compresses) during their hospital stay. They will apply the compresses for 15 minutes, up to four times a day, and record their pain levels in a diary. The study will take place in four hospitals in Quebec, Canada, and will involve a total of 104 participants.

Why it matters

Potential benefit: If successful, this treatment could provide significant pain relief for postpartum women experiencing perineal discomfort.

How similar studies have gone: While the use of magnesium sulfate for this purpose has not been extensively studied, similar approaches in pain management have shown promise in other contexts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Planned hospital stay at the mother-child unit of the Hôpital de Chicoutimi, Hôpital Charles-Le Moyne, or Hôpital Honoré-Mercier
* Vaginal delivery with or without perineal tear, any degree of tear, including episiotomies
* Obtaining consent for the study
* Languages spoken: French, English or both

Exclusion Criteria:

* Hemodynamic instability
* Surgical procedure such as a cesarean section
* Transfer to another hospital
* Transfer to another care unit
* Chronic use of narcotics
* Inability to complete the logbook
* Unsigned consent form

Where it's running

  • Hôpital Charles Lemoyne
    Greenfield Park, Quebec, Canada
    Recruiting
  • Hôpital de Chicoutimi
    Chicoutimi, Quebec, Canada
    Not yet recruiting
  • Hôpital Brome-Missisquoi-Perkins
    Cowansville, Quebec, Canada
    Not yet recruiting
  • Hôpital Honoré-Mercier
    Saint-Hyacinthe, Quebec, Canada
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.